Tetsuya Nakatsura

This inventor holds 12 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: National Cancer Center, Noile-Immune Biotech, Inc., Yamaguchi University. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuya Nakatsura. Retrieved from https://idiyas.com/inventor/tetsuya-nakatsura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 7)

% Patents Active = 58.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Kumamoto, JP (2010 - 2016)
Kashiwa, JP (2016)
Chiba, JP (2011 - 2023)

Company Filing History:

6 out of 264

National Cancer Center

patents

3 out of 3

Noile-Immune Biotech, Inc.

Oncotherapy Science, Incorporated

patents

5. 1 out of 7

Kanagawa Prefectural Hospital Organization

patents

6. 1 out of 6

Kumamoto Technology and Industry Foundation

Takeda Pharmaceutical Company Limited

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12505904 - Information management apparatus and non-transitory computer-readable recording medium (2025-12-23),

2. 12129291 - Anti-GPC3 antibody (2024-10-29),

3. 11718663 - Anti-GPC3 antibody (2023-08-08),

4. 11603519 - T-cell receptor (2023-03-14),

5. 10781249 - Anti-GPC3 antibody (2020-09-22),

6. 9505824 - Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation (2016-11-29),

7. 9465030 - Kit for diagnosing malignant melanoma (2016-10-11),

8. 9404925 - Cancer antigen and use thereof (2016-08-02),

9. 8535942 - Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same (2013-09-17),

10. 8053556 - Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same (2011-11-08),

11. 8017345 - Diagnostic kit for malignant melanoma (2011-09-13),

12. 7803533 - Diagnostic agent for malignant melanoma (2010-09-28),

Title: Tetsuya Nakatsura - Innovative Inventor from Chiba, Japan

Introduction: Tetsuya Nakatsura is a renowned inventor hailing from Chiba, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tetsuya Nakatsura holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, Nakatsura has worked with leading tech companies and research institutions, spearheading projects that have revolutionized the way we interact with technology.

Collaborations: Throughout his career, Tetsuya Nakatsura has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Tetsuya Nakatsura's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and creators worldwide.

Profile summary based on public USPTO records.